Why This DNA Tester Plummeted 38%, Leading A Medtech Sell-Off

Medical research stocks took a bath Thursday, led by BillionToOne's (BLLN) second-quarter report, featuring a widespread beat but no guidance raise. The company is a victim of its own success, said William Blair analyst Matt Larew. Up until the close on Wednesday, BillionToOne stock had climbed more than 84% since putting out its first-quarter report on May 6. "Both the…

8/03/2026 As stocks like Eli Lilly, Twilio, Hinge Health and more move ahead of earnings report, pay attention to these chart...

8/03/2026 As stocks like Eli Lilly, Twilio, Hinge Health and more...